查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662638

生物材料伤口敷料市场预测至 2030 年：按产品类型、材料类型、分销管道、应用、最终用户和地区进行的全球分析

Biomaterial Wound Dressing Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生物材料伤口敷料市场预计在 2024 年达到 62.8 亿美元，预计到 2030 年将达到 102 亿美元，预测期内的复合年增长率为 8.4%。

生物材料伤口敷料是用于创伤治疗和预防感染的先进材料。这些敷料由天然或合成的生物材料组成，例如硅胶、胶原蛋白、几丁聚醣和藻酸盐，可促进身体的癒合过程。它们可以形成一道抵御细菌的屏障，吸收渗出液，并创造一个潮湿的环境。生物材料伤口敷料常用于烧烫伤、慢性伤口、手术伤口和其他创伤性损伤，因为它们比传统伤口护理癒合更快、留下的疤痕更少。

根据2022年1月更新的国家糖尿病统计报告，美国约有3,730万人患有糖尿病，约占总人口的11.3%。

慢性伤口增多

随着人口老化以及糖尿病和肥胖症发病率的增加，糖尿病足溃疡、压疮和静脉性腿部溃疡等慢性伤口变得越来越普遍。这些伤口通常需要特殊护理并且难以癒合。生物材料伤口敷料由胶原蛋白、水凝胶和藻酸盐等尖端材料製成，可透过维持湿润环境、预防感染和减少疤痕的出现来提高癒合品质。随着患有慢性疾病的人数不断增加，对高效、先进的创伤护理产品（尤其是生物材料和敷料）的需求预计将呈指数级增长。

缺乏报销政策

与传统的伤口护理解决方案相比，许多新型生物材料敷料儘管具有卓越的创伤治疗，但价格昂贵。病患和医疗专业人员可能会因为财务问题而犹豫是否使用这些尖端治疗方法，尤其是在保险报销系统有限或不完美的地区。没有保险的患者和新兴市场探险者可能会受到最大影响。生物材料敷料的广泛使用往往因缺乏报销而受到限制，从而减缓了市场成长，并使公司更难成功进入价格敏感的市场。

对更快、更有效的创伤治疗的需求日益增加

胶原蛋白蛋白、亲水胶体和水凝胶敷料是一些先进生物材料敷料的例子，它们可以减少疤痕、降低感染风险并促进快速组织再生。透过创造湿润的伤口环境，这些敷料可以帮助患者更快癒合并减少不适。医疗保健专业人员对生物材料伤口敷料的使用推动了对此类尖端解决方案的需求。生物材料伤口敷料不仅可以加快癒合过程，而且由于更加重视改善患者治疗效果和降低医疗成本，还可以提供更高的舒适度和保护。

医疗专业人员的产品知识有限

儘管现代创伤护理产品（如生物材料敷料）具有显着的益处，包括加快癒合速度、预防感染疾病和减少疤痕，但许多医疗保健专业人员可能并未完全了解其好处或正确使用方法。这种无知可能会导致这种最尖端科技的利用不足，特别是在传统伤口护理仍然普遍的地区。为了增加生物材料敷料的使用量并改善患者的治疗效果，需要对医疗保健专业人员进行有关其功效和正确使用的教育，这将有助于扩大整个市场。

COVID-19 的影响

COVID-19 疫情以多种方式影响了生物材料伤口敷料市场。虽然停业和经济放缓最初扰乱了供应链并减少了某些领域的需求，但这场大流行凸显了创伤护理在医疗保健环境中的重要性。由于对感染预防和控制的重视程度不断提高，加上需要就医的新冠肺炎患者数量突然增加，导致某些类型的伤口敷料的需求暂时增加。然而，整体影响将根据具体调味料类型和当地市场情况而有所不同。

泡棉敷料市场预计将成为预测期内最大的市场

预测期内，泡棉敷料将占据最大的市场占有率。泡棉敷料非常适合处理中度至重度渗出伤口，可有效吸收液体，同时保持伤口湿润环境以促进癒合。它的缓衝作用可以减轻疼痛并提供额外的保护，使其成为慢性伤口、手术部位和压疮的理想选择。此外，由于其易于应用和移除，在伤口护理中越来越受欢迎。

预计预测期内医院和诊所部门将以最高的复合年增长率成长。

由于对先进创伤护理解决方案的需求很高，预计医院和诊所部门将在预测期内见证最高成长率。在这些医疗环境中，患有慢性伤口、手术伤口和烧伤的患者需要有效、快速癒合的产品。事实证明，生物材料和敷料具有显着的益处，包括改善感染控制、加速癒合时间和减少併发症。随着医院和诊所寻求改善患者的治疗效果并降低医疗成本，采用可提供最佳癒合环境的生物材料伤口敷料越来越成为这些机构的优先事项。

比最大的地区

由于慢性伤口、烧伤和糖尿病相关疾病的发生率不断上升，预计亚太地区将在预测期内占据最大的市场占有率。印度和中国等国家快速的都市化、不断增强的医疗意识和不断扩大的医疗保健基础设施正在推动对先进创伤护理解决方案的需求。此外，该地区人口老化，老年人更容易受到伤口的影响，需要使用生物材料敷料进行有效治疗，以加速癒合并预防感染。

复合年增长率最高的地区

预计北美地区在预测期内将呈现最高的复合年增长率。这是由于医疗费用高昂、医疗基础设施先进以及人口老化所造成的。慢性伤口、糖尿病和外科手术的增加推动了对先进创伤护理产品的需求。医院、诊所和家庭护理机构越来越多地采用生物材料敷料，因为它们可以加快癒合速度、预防感染并提高患者舒适度，这对北美市场产生了积极影响。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生物材料伤口敷料市场依产品类型划分

  • 介绍
  • 泡棉敷料
  • 亲水胶体敷料
  • 水凝胶
  • 膜敷料
  • 复合敷料
  • 其他的

6. 全球生物材料伤口敷料市场（依材料类型）

  • 介绍
  • 胶原蛋白
  • 几丁聚醣
  • 硅胶
  • 亲水胶体
  • 表格
  • 海藻酸盐
  • 其他的

7. 全球生物材料伤口敷料市场依通路划分

  • 介绍
  • 直接销售
  • 零售药局
  • 网上销售
  • 医院和医疗保健提供者

8. 全球生物材料伤口敷料市场（依应用）

  • 介绍
  • 急性伤口
    • 手术伤口
    • 烧伤
  • 慢性伤口
    • 糖尿病足溃疡
    • 静脉性腿部溃疡
    • 压疮
  • 创伤
  • 其他的

9. 全球生物材料伤口敷料市场（依最终使用者）

  • 介绍
  • 医院和诊所
  • 居家医疗
  • 门诊手术中心
  • 长期照护机构
  • 其他的

第 10 章全球生物材料伤口敷料市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • 3M Health Care
  • Johnson & Johnson
  • Smith & Nephew
  • Medtronic
  • Molnlycke Health Care
  • ConvaTec Group
  • Coloplast
  • BSN Medical
  • Hollister Incorporated
  • Systagenix Wound Management
  • Derma Sciences
  • KCI
  • B. Braun Melsungen AG
  • 美美国
  • Integra LifeSciences Corporation
Product Code: SMRC28499

According to Stratistics MRC, the Global Biomaterial Wound Dressing Market is accounted for $6.28 billion in 2024 and is expected to reach $10.20 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Biomaterial Wound Dressing are advanced materials which are intended for wound healing and prevent infection. These dressings, which promote the body's healing processes, are composed of natural or synthetic biomaterials such silicone, collagen, chitosan, and alginates. They offer a barrier against germs, absorb exudate, and produce a moist environment. Biomaterial wound dressings, which offer faster healing times and less scarring than conventional wound care treatments, are frequently used for burns, chronic wounds, surgical wounds, and other traumas.

According to the National Diabetes Statistics Report updated in January 2022, around 37.3 million people in the United States have diabetes, which equates to around 11.3% of the total population.

Market Dynamics:

Driver:

Rising incidence of chronic wounds

As the population ages and diabetes and obesity rates rise, chronic wounds including diabetic foot ulcers, pressure ulcers, and venous leg ulcers are becoming more prevalent. These wounds frequently need specialized care and are challenging to cure. By preserving a moist environment, avoiding infection, and lessening scarring, biomaterial wound dressings-which comprise cutting-edge materials like collagen, hydrogels, and alginates-offer improved healing qualities. The need for efficient, cutting-edge wound care products, especially biomaterial dressings, is anticipated to expand sharply as the number of people with chronic illnesses keeps growing.

Restraint:

Lack of reimbursement policies

Compared to conventional wound care solutions, many new biomaterial dressings are more expensive despite providing better wound healing advantages. Patients and healthcare professionals may be hesitant to use these cutting-edge treatments in areas with limited or incomplete reimbursement schemes because of financial concerns. Individuals without full health coverage or those in developing markets may be most affected by this. The widespread use of biomaterial dressings is frequently restricted by the lack of reimbursement, which slows market growth and makes it more challenging for businesses to successfully enter price-sensitive markets.

Opportunity:

Growing demand for faster and efficient wound healing

Collagen-based, hydrocolloid, and hydrogel dressings are examples of advanced biomaterial dressings that decrease scarring, lower the risk of infection, and encourage quick tissue regeneration. By creating a moist wound environment, these dressings help patients heal more quickly and experience less discomfort. The demand for these cutting-edge solutions is being driven by healthcare professionals' use of biomaterial wound dressings, which not only speed up the healing process but also offer improved comfort and protection, as a result of the growing emphasis on improving patient outcomes and lowering healthcare costs.

Threat:

Limited product knowledge among healthcare providers

Many healthcare practitioners might not be completely aware of the benefits of modern wound care products, such as biomaterial dressings, or the correct administration procedures, despite the fact that these products offer substantial advantages like faster healing, infection control, and less scarring. This ignorance may lead to the underuse of these cutting-edge technologies, especially in areas where conventional wound care practices are still widely used. Increasing the use of biomaterial dressings and improving patient outcomes need educating healthcare professionals on their efficacy and appropriate usage, which will assist the market's overall expansion.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the biomaterial wound dressing market. While lockdowns and economic slowdowns initially disrupted supply chains and reduced demand in some sectors, the pandemic also highlighted the importance of wound care in healthcare settings. Increased focus on infection prevention and control measures, along with the surge in COVID-19 patients requiring medical attention, led to a temporary increase in demand for certain types of wound dressings. However, the overall impact varied depending on the specific type of dressing and regional market conditions.

The foam dressings segment is expected to be the largest during the forecast period

The foam dressings segment is expected to account for the largest market share during the forecast period. Foam dressings are ideal for managing moderate to heavy exudating wounds, as they efficiently absorb fluids while maintaining a moist wound environment, which accelerates healing. Their cushioning effect reduces pain and provides additional protection, making them a preferred choice for chronic wounds, surgical sites, and pressure ulcers. Additionally, their ease of application and removal contributes to their rising popularity in wound care.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals and clinics segment is predicted to witness the highest growth rate, due to their high demand for advanced wound care solutions. These healthcare settings require effective, fast-healing products for patients with chronic wounds, surgical wounds, and burns. Biomaterial dressings offer superior benefits like infection control, faster healing times, and reduced complications. As hospitals and clinics aim to improve patient outcomes and reduce healthcare costs, the adoption of biomaterial wound dressings, which provide optimal healing environments, is increasingly prioritized in these facilities.

Region with largest share:

During the forecast period, Asia Pacific region is expected to hold the largest market share, due to the rising prevalence of chronic wounds, burns, and diabetic-related conditions. Rapid urbanization, rising healthcare awareness and the expansion of healthcare infrastructure in countries like India and China are driving the demand for advanced wound care solutions. Additionally, the aging population in the region further contributes to the market growth, as elderly individuals are more prone to wounds that require effective treatment with biomaterial dressings for faster healing and infection control.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by high healthcare spending, advanced medical infrastructure, and a growing aging population. With an increasing prevalence of chronic wounds, diabetes, and surgical procedures, the demand for advanced wound care products is on the rise. The adoption of biomaterial dressings, which offer faster healing, infection prevention, and improved patient comfort, is growing across hospitals, clinics, and home care settings, positively influencing the market in North America.

Key players in the market

Some of the key players profiled in the Biomaterial Wound Dressing Market include 3M Health Care, Johnson & Johnson, Smith & Nephew, Medtronic, Molnlycke Health Care, ConvaTec Group, Coloplast, BSN Medical, Hollister Incorporated, Systagenix Wound Management, Derma Sciences, KCI, B. Braun Melsungen AG, Medi-USA, and Integra LifeSciences Corporation.

Key Developments:

In January 2025, Molnlycke Health Care, a world-leading MedTech company specialising in wound care solutions, announced an investment of USD 8 million in Siren. The healthcare tech company Siren is on a mission to help reduce the risk of diabetic foot ulcers by early detection of potential injuries through temperature-sensing textile technology.

In January 2025, Johnson & Johnson strengthens neuroscience leadership with acquisition of intra-cellular therapies, Inc. Acquisition includes CAPLYTA(R) (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults.

In December 2024, Smith+Nephew expands AETOS shoulder system with new stemless option for anatomic shoulder arthroplasty. Smith+Nephew announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total shoulder for the AETOS Shoulder System (AETOS Stemless).

Product Types Covered:

  • Foam Dressings
  • Hydrocolloid Dressings
  • Hydrogels
  • Film Dressings
  • Composite Dressings
  • Other Product Types

Material Types Covered:

  • Collagen
  • Chitosan
  • Silicone
  • Hydrocolloid
  • Foam
  • Alginate
  • Other Material Types

Distribution Channels Covered:

  • Direct Sales
  • Retail Pharmacies
  • Online Sales
  • Hospitals and Healthcare Providers

Applications Covered:

  • Acute Wounds
  • Chronic Wounds
  • Traumatic Wounds
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Long-Term Care Facilities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biomaterial Wound Dressing Market, By Product Type

  • 5.1 Introduction
  • 5.2 Foam Dressings
  • 5.3 Hydrocolloid Dressings
  • 5.4 Hydrogels
  • 5.5 Film Dressings
  • 5.6 Composite Dressings
  • 5.7 Other Product Types

6 Global Biomaterial Wound Dressing Market, By Material Type

  • 6.1 Introduction
  • 6.2 Collagen
  • 6.3 Chitosan
  • 6.4 Silicone
  • 6.5 Hydrocolloid
  • 6.6 Foam
  • 6.7 Alginate
  • 6.8 Other Material Types

7 Global Biomaterial Wound Dressing Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Retail Pharmacies
  • 7.4 Online Sales
  • 7.5 Hospitals and Healthcare Providers

8 Global Biomaterial Wound Dressing Market, By Application

  • 8.1 Introduction
  • 8.2 Acute Wounds
    • 8.2.1 Surgical Wounds
    • 8.2.2 Burns
  • 8.3 Chronic Wounds
    • 8.3.1 Diabetic Foot Ulcers
    • 8.3.2 Venous Leg Ulcers
    • 8.3.1 Pressure Ulcers
  • 8.4 Traumatic Wounds
  • 8.5 Other Applications

9 Global Biomaterial Wound Dressing Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals and Clinics
  • 9.3 Home Care Settings
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Long-Term Care Facilities
  • 9.6 Other End Users

10 Global Biomaterial Wound Dressing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 3M Health Care
  • 12.2 Johnson & Johnson
  • 12.3 Smith & Nephew
  • 12.4 Medtronic
  • 12.5 Molnlycke Health Care
  • 12.6 ConvaTec Group
  • 12.7 Coloplast
  • 12.8 BSN Medical
  • 12.9 Hollister Incorporated
  • 12.10 Systagenix Wound Management
  • 12.11 Derma Sciences
  • 12.12 KCI
  • 12.13 B. Braun Melsungen AG
  • 12.14 Medi-USA
  • 12.15 Integra LifeSciences Corporation

List of Tables

  • Table 1 Global Biomaterial Wound Dressing Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Biomaterial Wound Dressing Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Biomaterial Wound Dressing Market Outlook, By Foam Dressings (2022-2030) ($MN)
  • Table 4 Global Biomaterial Wound Dressing Market Outlook, By Hydrocolloid Dressings (2022-2030) ($MN)
  • Table 5 Global Biomaterial Wound Dressing Market Outlook, By Hydrogels (2022-2030) ($MN)
  • Table 6 Global Biomaterial Wound Dressing Market Outlook, By Film Dressings (2022-2030) ($MN)
  • Table 7 Global Biomaterial Wound Dressing Market Outlook, By Composite Dressings (2022-2030) ($MN)
  • Table 8 Global Biomaterial Wound Dressing Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 9 Global Biomaterial Wound Dressing Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 10 Global Biomaterial Wound Dressing Market Outlook, By Collagen (2022-2030) ($MN)
  • Table 11 Global Biomaterial Wound Dressing Market Outlook, By Chitosan (2022-2030) ($MN)
  • Table 12 Global Biomaterial Wound Dressing Market Outlook, By Silicone (2022-2030) ($MN)
  • Table 13 Global Biomaterial Wound Dressing Market Outlook, By Hydrocolloid (2022-2030) ($MN)
  • Table 14 Global Biomaterial Wound Dressing Market Outlook, By Foam (2022-2030) ($MN)
  • Table 15 Global Biomaterial Wound Dressing Market Outlook, By Alginate (2022-2030) ($MN)
  • Table 16 Global Biomaterial Wound Dressing Market Outlook, By Other Material Types (2022-2030) ($MN)
  • Table 17 Global Biomaterial Wound Dressing Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 18 Global Biomaterial Wound Dressing Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 19 Global Biomaterial Wound Dressing Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 20 Global Biomaterial Wound Dressing Market Outlook, By Online Sales (2022-2030) ($MN)
  • Table 21 Global Biomaterial Wound Dressing Market Outlook, By Hospitals and Healthcare Providers (2022-2030) ($MN)
  • Table 22 Global Biomaterial Wound Dressing Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 Global Biomaterial Wound Dressing Market Outlook, By Acute Wounds (2022-2030) ($MN)
  • Table 24 Global Biomaterial Wound Dressing Market Outlook, By Surgical Wounds (2022-2030) ($MN)
  • Table 25 Global Biomaterial Wound Dressing Market Outlook, By Burns (2022-2030) ($MN)
  • Table 26 Global Biomaterial Wound Dressing Market Outlook, By Chronic Wounds (2022-2030) ($MN)
  • Table 27 Global Biomaterial Wound Dressing Market Outlook, By Diabetic Foot Ulcers (2022-2030) ($MN)
  • Table 28 Global Biomaterial Wound Dressing Market Outlook, By Venous Leg Ulcers (2022-2030) ($MN)
  • Table 29 Global Biomaterial Wound Dressing Market Outlook, By Pressure Ulcers (2022-2030) ($MN)
  • Table 30 Global Biomaterial Wound Dressing Market Outlook, By Traumatic Wounds (2022-2030) ($MN)
  • Table 31 Global Biomaterial Wound Dressing Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 32 Global Biomaterial Wound Dressing Market Outlook, By End User (2022-2030) ($MN)
  • Table 33 Global Biomaterial Wound Dressing Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 34 Global Biomaterial Wound Dressing Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 35 Global Biomaterial Wound Dressing Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 36 Global Biomaterial Wound Dressing Market Outlook, By Long-Term Care Facilities (2022-2030) ($MN)
  • Table 37 Global Biomaterial Wound Dressing Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.